Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Cancer Immunology, Immunotherapy : CII
|
April 9, 2008
Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation
Dan Zhu, Laura G Corral, Yuedi W Fleming, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2003
Alpha-fluoro-substituted thalidomide analogues
Hon-Wah Man, Laura G Corral, David I Stirling, et al.
Blood
|
May 4, 2011
Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
Steffen E Meiler, Marlene Wade, Ferdane Kutlar, et al.
Blood
|
May 7, 2009
Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases
Yibing Xu, Jianwu Li, Gregory D Ferguson, et al.
The Journal of Clinical Investigation
|
December 8, 2007
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells
Laure A Moutouh-de Parseval, Dominique Verhelle, Emilia Glezer, et al.
Journal of Clinical Immunology
|
February 20, 2007
Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2
Gregory D Ferguson, Kristen Jensen-Pergakes, Candice Wilkey, et al.
Blood
|
July 4, 2014
Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21(WAF1/Cip1)-dependent mechanism independent of functional p53
Jessie-F Fecteau, Laura G Corral, Emanuela M Ghia, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
June 28, 2018
A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure
Jessica M Bradley, Pablo Spaletra, Zhen Li, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs
Peter H Schafer, Anita K Gandhi, Michelle A Loveland, et al.
Journal of Medicinal Chemistry
|
March 5, 2009
Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor
Hon-Wah Man, Peter Schafer, Lu Min Wong, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Cancer Immunology, Immunotherapy : CII
|
April 9, 2008
Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation
Dan Zhu, Laura G Corral, Yuedi W Fleming, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2003
Alpha-fluoro-substituted thalidomide analogues
Hon-Wah Man, Laura G Corral, David I Stirling, et al.
Blood
|
May 4, 2011
Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
Steffen E Meiler, Marlene Wade, Ferdane Kutlar, et al.
Blood
|
May 7, 2009
Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases
Yibing Xu, Jianwu Li, Gregory D Ferguson, et al.
The Journal of Clinical Investigation
|
December 8, 2007
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells
Laure A Moutouh-de Parseval, Dominique Verhelle, Emilia Glezer, et al.
Journal of Clinical Immunology
|
February 20, 2007
Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2
Gregory D Ferguson, Kristen Jensen-Pergakes, Candice Wilkey, et al.
Blood
|
July 4, 2014
Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21(WAF1/Cip1)-dependent mechanism independent of functional p53
Jessie-F Fecteau, Laura G Corral, Emanuela M Ghia, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
June 28, 2018
A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure
Jessica M Bradley, Pablo Spaletra, Zhen Li, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs
Peter H Schafer, Anita K Gandhi, Michelle A Loveland, et al.
Journal of Medicinal Chemistry
|
March 5, 2009
Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor
Hon-Wah Man, Peter Schafer, Lu Min Wong, et al.
Page
of 2